Trial Outcomes & Findings for Post-Approval Clinical Trial Comparing the Long Term Safety and Effectiveness Coflex vs. Fusion to Treat Lumbar Spinal Stenosis (NCT NCT00534235)

NCT ID: NCT00534235

Last Updated: 2020-02-06

Results Overview

The primary variable of performance is the assessment of Oswestry Low Back Pain Disability Index (ODI) in both treatment groups at 5 years. It will be assessed if the improvement in ODI since the pre surgery status in the coflex™ group is better than the improvement in the control group (scale 0-100 with a higher score representing increased disability).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

322 participants

Primary outcome timeframe

5 years

Results posted on

2020-02-06

Participant Flow

Participant milestones

Participant milestones
Measure
Posterolateral Fusion w/Pedicle Screws
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Overall Study
STARTED
107
215
Overall Study
COMPLETED
91
192
Overall Study
NOT COMPLETED
16
23

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Post-Approval Clinical Trial Comparing the Long Term Safety and Effectiveness Coflex vs. Fusion to Treat Lumbar Spinal Stenosis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Total
n=322 Participants
Total of all reporting groups
Age, Continuous
64.1 years
STANDARD_DEVIATION 9.0 • n=5 Participants
62.1 years
STANDARD_DEVIATION 9.2 • n=7 Participants
62.8 years
STANDARD_DEVIATION 9.2 • n=5 Participants
Sex: Female, Male
Female
58 Participants
n=5 Participants
106 Participants
n=7 Participants
164 Participants
n=5 Participants
Sex: Female, Male
Male
49 Participants
n=5 Participants
109 Participants
n=7 Participants
158 Participants
n=5 Participants
Race/Ethnicity, Customized
American Indian / Alaskan Native
3 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
3 Participants
n=5 Participants
4 Participants
n=7 Participants
7 Participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American
6 Participants
n=5 Participants
11 Participants
n=7 Participants
17 Participants
n=5 Participants
Race/Ethnicity, Customized
White
93 Participants
n=5 Participants
191 Participants
n=7 Participants
284 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
2 Participants
n=5 Participants
8 Participants
n=7 Participants
10 Participants
n=5 Participants
Region of Enrollment
United States
107 participants
n=5 Participants
215 participants
n=7 Participants
322 participants
n=5 Participants
Weight
187.7 pounds
STANDARD_DEVIATION 38.1 • n=5 Participants
190.3 pounds
STANDARD_DEVIATION 35.4 • n=7 Participants
189.5 pounds
STANDARD_DEVIATION 36.3 • n=5 Participants
Height
66.6 inches
STANDARD_DEVIATION 4.1 • n=5 Participants
67.0 inches
STANDARD_DEVIATION 4.1 • n=7 Participants
66.9 inches
STANDARD_DEVIATION 4.1 • n=5 Participants
Current Smoker
Yes
15 Participants
n=5 Participants
22 Participants
n=7 Participants
37 Participants
n=5 Participants
Current Smoker
No
92 Participants
n=5 Participants
193 Participants
n=7 Participants
285 Participants
n=5 Participants
Comorbidities
Cardiovascular
74 Participants
n=5 Participants
137 Participants
n=7 Participants
211 Participants
n=5 Participants
Comorbidities
Musculoskeletal
61 Participants
n=5 Participants
112 Participants
n=7 Participants
173 Participants
n=5 Participants
Comorbidities
Endocrine
35 Participants
n=5 Participants
55 Participants
n=7 Participants
90 Participants
n=5 Participants
Duration of Back Pain
None
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Duration of Back Pain
Fewer than 6 months
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Duration of Back Pain
6 months to a year
14 Participants
n=5 Participants
24 Participants
n=7 Participants
38 Participants
n=5 Participants
Duration of Back Pain
More than one year
92 Participants
n=5 Participants
188 Participants
n=7 Participants
280 Participants
n=5 Participants
Duration of Leg Pain (maximum)
None
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Duration of Leg Pain (maximum)
Fewer than 6 months
8 Participants
n=5 Participants
6 Participants
n=7 Participants
14 Participants
n=5 Participants
Duration of Leg Pain (maximum)
6 months to a year
22 Participants
n=5 Participants
38 Participants
n=7 Participants
60 Participants
n=5 Participants
Duration of Leg Pain (maximum)
More than one year
76 Participants
n=5 Participants
170 Participants
n=7 Participants
246 Participants
n=5 Participants
Duration of Buttock Pain
None
21 Participants
n=5 Participants
32 Participants
n=7 Participants
53 Participants
n=5 Participants
Duration of Buttock Pain
Fewer than 6 months
7 Participants
n=5 Participants
11 Participants
n=7 Participants
18 Participants
n=5 Participants
Duration of Buttock Pain
6 months to a year
22 Participants
n=5 Participants
41 Participants
n=7 Participants
63 Participants
n=5 Participants
Duration of Buttock Pain
More than one year
57 Participants
n=5 Participants
131 Participants
n=7 Participants
188 Participants
n=5 Participants
Duration of Groin Pain
None
74 Participants
n=5 Participants
157 Participants
n=7 Participants
231 Participants
n=5 Participants
Duration of Groin Pain
Fewer than 6 months
5 Participants
n=5 Participants
6 Participants
n=7 Participants
11 Participants
n=5 Participants
Duration of Groin Pain
6 months to a year
12 Participants
n=5 Participants
13 Participants
n=7 Participants
25 Participants
n=5 Participants
Duration of Groin Pain
More than one year
16 Participants
n=5 Participants
39 Participants
n=7 Participants
55 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 5 years

Population: The accounting #s in the Patient Flow include all subjects available for CCS evaluation; therefore, the overall # of participants analyzed for each Outcome Measure will differ from the number provided in the Participant Flow as the number provided for each Outcome Measure is the number of patients who completed or were assessed for that measure.

The primary variable of performance is the assessment of Oswestry Low Back Pain Disability Index (ODI) in both treatment groups at 5 years. It will be assessed if the improvement in ODI since the pre surgery status in the coflex™ group is better than the improvement in the control group (scale 0-100 with a higher score representing increased disability).

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With Improvement of at Least 15 Points in ODI
41 Participants
101 Participants

PRIMARY outcome

Timeframe: 5 years

Assessment of secondary surgical interventions, i.e., reoperations, revisions, removals, or supplemental fixation associated with either coflex or control group. Refer to FDA guidance for complete definitions (https://www.fda.gov/RegulatoryInformation/Guidances/ucm072263.htm).

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With no Reoperations, Revisions, Removals, or Supplemental Fixation
87 Participants
179 Participants

PRIMARY outcome

Timeframe: 5 years

Assessment of major device-related complications at 5 years

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With no Major Device Related Complications
100 Participants
212 Participants

PRIMARY outcome

Timeframe: 5 years

Assessment of lumbar epidural injections

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With no Epidural Injection(s)
84 Participants
177 Participants

PRIMARY outcome

Timeframe: 5 years

No persistent new or increasing sensory or motor deficit

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=145 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With no Persistent New or Increasing Sensory or Motor Deficit
70 Participants
135 Participants

PRIMARY outcome

Timeframe: 5 years

No persistent new or increasing sensory deficit

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=75 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=146 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With no Persistent New or Increasing Sensory Deficit
72 Participants
137 Participants

PRIMARY outcome

Timeframe: 5 years

No persistent new or increasing motor deficit

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=146 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With no Persistent New or Increasing Motor Deficit
72 Participants
144 Participants

PRIMARY outcome

Timeframe: 5 years

No reoperations, revisions, removals or supplemental fixation and no epidural injection at any lumbar level up to and including the Month 60 visit.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With no Reoperations or Epidural (Up to Day 1825)
71 Participants
149 Participants

SECONDARY outcome

Timeframe: 5 years

ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With a Decrease in Zurich Claudication Questionnaire (ZCQ) Symptom Severity of at Least 0.5 Points
40 Participants
100 Participants

SECONDARY outcome

Timeframe: 5 years

ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With Decrease in Zurich Claudication Questionnaire (ZCQ) Physical Function of at Least 0.5 Points
38 Participants
98 Participants

SECONDARY outcome

Timeframe: 5 years

Assessment of the patient's Quality of Life as measured by SF-12. Scores range from 0 to 100, where a zero score indicates the lowest level of health. Success was defined as subjects who maintained or improved from their SF-12 score at baseline.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=44 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=106 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With Maintenance or Improvement in SF-12 Physical Function Component
34 Participants
93 Participants

SECONDARY outcome

Timeframe: 5 years

Assessment of the patient's Quality of Life as measured by SF-12. Scores range from 0 to 100, where a zero score indicates the lowest level of health. Success was defined as subjects who maintained or improved from their SF-12 score at baseline.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=44 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=106 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With Maintenance or Improvement in SF-12 Mental Health Component
31 Participants
72 Participants

SECONDARY outcome

Timeframe: 5 years

Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=53 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With a Decrease in VAS Back Pain of at Least 20mm
40 Participants
104 Participants

SECONDARY outcome

Timeframe: 5 years

Improvement of the Visual Analog Scale (VAS) for leg pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=53 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With Decrease VAS Worse Leg Pain of at Least 20mm
41 Participants
99 Participants

SECONDARY outcome

Timeframe: 5 years

Assessment of disability from low back pain as measured by ODI (Oswestry Disability Index) mean score in each treatment group at 5 years. On a scale of 0-100, a higher score represents increased disability.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Oswestry Disability Index (ODI) Score
26.1 units on a scale
Standard Deviation 22.2
24.5 units on a scale
Standard Deviation 20.5

SECONDARY outcome

Timeframe: 5 years

Assessment of Back Pain as measured by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Visual Analog Scale Back Pain Score
29.0 mm
Standard Deviation 31.0
25.4 mm
Standard Deviation 27.6

SECONDARY outcome

Timeframe: 5 years

Assessment of Worse Leg Pain by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Visual Analog Scale Leg (Worse) Pain Score
25.2 mm
Standard Deviation 31.2
22.8 mm
Standard Deviation 28.1

SECONDARY outcome

Timeframe: 5 years

Assessment of Right Leg Pain by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Visual Analog Scale (VAS) Leg (Right) Pain Score
16.0 mm
Standard Deviation 24.5
14.9 mm
Standard Deviation 21.6

SECONDARY outcome

Timeframe: 5 years

Assessment of Left Leg Pain by VAS mean score in both treatment groups at 5 years. On a scale of 0-100mm, a higher score represents worse pain.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Visual Analog Scale (VAS) Leg (Left) Pain Score
17.0 mm
Standard Deviation 26.8
18.4 mm
Standard Deviation 27.0

SECONDARY outcome

Timeframe: 5 years

Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=53 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With a Decrease in VAS Right Leg Pain of at Least 20mm
36 Participants
90 Participants

SECONDARY outcome

Timeframe: 5 years

Improvement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=53 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=122 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Number of Subjects With a Decrease in VAS Left Leg Pain of at Least 20mm
37 Participants
78 Participants

SECONDARY outcome

Timeframe: 5 years

Assessment of symptom severity by ZCQ mean score in both treatment groups at 5 years. ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Zurich Claudication Questionnaire (ZCQ) Symptom Severity Score
2.17 units on a scale
Standard Deviation 0.85
2.08 units on a scale
Standard Deviation 0.84

SECONDARY outcome

Timeframe: 5 years

Assessment of physical function by ZCQ mean score in both groups at 5 years. ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Zurich Claudication Questionnaire (ZCQ) Physical Function Score
1.81 units on a scale
Standard Deviation 0.79
1.67 units on a scale
Standard Deviation 0.68

SECONDARY outcome

Timeframe: 5 years

Assessment of the patient's Quality of Life as measured by SF-12 mean score in both treatment groups at 5 years. Scores range from 0 to 100, where a zero score indicates the lowest level of health.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=47 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=118 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Short Form-12 Physical Component Score
42.1 units on a scale
Standard Deviation 12.6
42.1 units on a scale
Standard Deviation 11.2

SECONDARY outcome

Timeframe: 5 years

Assessment of the patient's Quality of Life as measured by SF-12 mean score in both treatment groups at 5 years. Scores range from 0 to 100, where a zero score indicates the lowest level of health.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=47 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=118 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Short Form-12 Mental Component Score
54.8 units on a scale
Standard Deviation 8.4
54.1 units on a scale
Standard Deviation 9.7

SECONDARY outcome

Timeframe: 5 years

Subjects who responded "Very Satisfied" or "Somewhat Satisfied".

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=87 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=160 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Patient Survey: Satisfaction
72 Participants
151 Participants

SECONDARY outcome

Timeframe: 5 years

Subjects who responded "Definitely Yes" or "Probably Yes"

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=87 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=160 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Patient Survey: Recommendation of Treatment
70 Participants
145 Participants

SECONDARY outcome

Timeframe: 5 years

Number of subjects using Class II narcotics

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=81 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=156 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Pain Management: Class II Narcotics Usage by Device Group
17 Participants
32 Participants

SECONDARY outcome

Timeframe: 5 years

Number of subjects using NSAIDs/ASA/Acetaminophen

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=81 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=156 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Pain Management: NSAIDs/ASA/Acetaminophen Usage by Device Group
24 Participants
55 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=105 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Mean Rotation (F to E) in Degrees - At Level(s) of Implant
0.98 degrees
Standard Deviation 1.17
3.13 degrees
Standard Deviation 3.43

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at the level below the 1- or 2-level device construct in both groups.

As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the level below the implant in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=140 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Rotation (F to E) in Degrees - Below Level of Implant
5.62 degrees
Standard Deviation 3.69
5.83 degrees
Standard Deviation 4.17

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at the level above the 1- or 2-level device construct in both groups.

As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the level above the implant in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=76 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=146 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Rotation (F to E) in Degrees - Above Level of Implant
3.59 degrees
Standard Deviation 2.89
3.52 degrees
Standard Deviation 3.16

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average measure of translation at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=103 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=204 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Translation (mm) - At Level(s) of Implant
0.23 mm
Standard Deviation 0.32
0.82 mm
Standard Deviation 0.84

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at the level below the 1- or 2-level device construct in both groups.

As determined by independent radiographic lab, this is the average measure of translation at the level below the implant in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=72 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=139 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Translation (mm) - Below Level of Implant
0.63 mm
Standard Deviation 0.57
0.64 mm
Standard Deviation 0.61

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at the level above the 1- or 2-level device construct in both groups.

As determined by independent radiographic lab, this is the average measure of translation at the level above the implant in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=145 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Translation (mm) - Above Level of Implant
0.69 mm
Standard Deviation 0.57
0.83 mm
Standard Deviation 0.80

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average measure of anterior disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Anterior Disc Height (mm) - At Level(s) of Implant
8.13 mm
Standard Deviation 3.19
8.89 mm
Standard Deviation 3.68

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average measure of posterior disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Posterior Disc Height (mm) - At Level(s) of Implant
4.56 mm
Standard Deviation 1.65
4.46 mm
Standard Deviation 1.89

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the percentage of translation at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=105 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Translation (F to E) in Percent (%) - At Level(s) of Implant
0.69 percent
Standard Deviation 0.89
2.38 percent
Standard Deviation 2.43

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at the level below the 1- or 2-level device construct in both groups.

As determined by independent radiographic lab, this is the percentage of translation at the level below the implant in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=140 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Translation (F to E) in Percent (%) - Below Level of Implant
1.95 percent
Standard Deviation 1.95
1.97 percent
Standard Deviation 1.88

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at the level above the 1- or 2-level device construct in both groups.

As determined by independent radiographic lab, this is the percentage of translation at the level above the implant in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=76 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=146 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Translation (F to E) in Percent (%) - Above Level of Implant
2.07 percent
Standard Deviation 1.68
2.40 percent
Standard Deviation 2.31

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average measure of disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Average Disc Height (mm) - At Level(s) of Implant
6.34 mm
Standard Deviation 2.09
6.67 mm
Standard Deviation 2.45

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average change from baseline for anterior disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=106 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=200 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Pre-Op Anterior Disc Height (mm) - At Level(s) of Implant
-1.38 mm
Standard Deviation 1.58
-1.32 mm
Standard Deviation 1.75

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average change from baseline for posterior disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=106 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=149 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Pre-Op Posterior Disc Height (mm) - At Level(s) of Implant
-0.49 mm
Standard Deviation 1.19
-0.72 mm
Standard Deviation 1.26

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average change from baseline for disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=106 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=200 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Pre-Op Average Disc Height (mm) - At Level(s) of Implant
-0.93 mm
Standard Deviation 1.02
-1.02 mm
Standard Deviation 1.24

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average change from immediate post-op for anterior disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Post-Op Anterior Disc Height (mm) - At Level(s) of Implant
-1.82 mm
Standard Deviation 1.39
-0.98 mm
Standard Deviation 2.06

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average change from immediate post-op for posterior disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Post-Op Posterior Disc Height (mm) - At Level(s) of Implant
-0.85 mm
Standard Deviation 1.00
-1.90 mm
Standard Deviation 1.65

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the average change from immediate post-op for disc height at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Post-Op Average Disc Height (mm) - At Level(s) of Implant
-1.33 mm
Standard Deviation 0.97
-1.44 mm
Standard Deviation 1.47

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the mean disc angle at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Disc Angle in Degrees - At Level(s) of Implant
6.02 degrees
Standard Deviation 4.64
7.28 degrees
Standard Deviation 5.19

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the mean change in disc angle from baseline at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=109 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=200 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Pre-Op Disc Angle in Degrees - At Level(s) of Implant
-1.41 degrees
Standard Deviation 3.10
-1.00 degrees
Standard Deviation 2.91

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the mean change in disc angle from immediate post-op at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Post-Op Disc Angle in Degrees - At Level(s) of Implant
-1.57 degrees
Standard Deviation 2.25
1.56 degrees
Standard Deviation 3.82

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the measure of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant
-1.08 mm
Standard Deviation 3.37
-1.01 mm
Standard Deviation 3.78

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the measure of the percentage of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Post-Op Spondylolisthesis (%) - At Level(s) of Implant
-3.4 percent
Standard Deviation 9.9
-3.2 percent
Standard Deviation 11.2

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the mean change in measure of spondylolisthesis at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=106 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=200 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Pre-Op Spondylolisthesis (mm) - At Level(s) of Implant
-0.12 mm
Standard Deviation 2.28
-0.56 mm
Standard Deviation 1.82

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

As determined by independent radiographic lab, this is the mean change in measure of spondylolisthesis from immediate post-op at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant
-0.77 mm
Standard Deviation 1.92
-0.44 mm
Standard Deviation 1.91

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

This is the mean foraminal height via x-ray at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=205 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Foraminal Height (X-ray) (mm) - At Level(s) of Implant
17.33 mm
Standard Deviation 2.75

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

This is the mean change in foraminal height via x-ray from baseline at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=200 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Pre-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant
-0.47 mm
Standard Deviation 1.29

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

This is the mean change in foraminal height via x-ray from immediate post-op at the index level(s) in both treatment groups at 5 years.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=149 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Change From Post-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant
-1.81 mm
Standard Deviation 1.74

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

Bridging through the posterolateral gutters, between the facet joints, between transverse processes, and/or between facet joint and transverse process will all be considered acceptable forms of bridging bone.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=209 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Bony Bridging
NA
0 Levels
209 Levels
Bony Bridging
No
17 Levels
0 Levels
Bony Bridging
Yes
84 Levels
0 Levels
Bony Bridging
Indeterminate
10 Levels
0 Levels

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

Assessment applicable to coflex arm only. The assessment applies to bony formations that occur in and around the implant.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=209 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Heterotopic Ossification
NA
0 participants
Heterotopic Ossification
None
91 participants
Heterotopic Ossification
Grade I
0 participants
Heterotopic Ossification
Grade II
24 participants
Heterotopic Ossification
Grade III
73 participants
Heterotopic Ossification
Bony Bridging
3 participants
Heterotopic Ossification
Indeterminate
18 participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

The assessment is an analysis of three component factors: Bridging Bone, Angular Motion and Translational Motion.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=209 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Fusion Status
NA
0 Levels
0 Levels
Fusion Status
Not fused
19 Levels
196 Levels
Fusion Status
Fused
78 Levels
3 Levels
Fusion Status
Indeterminate
14 Levels
10 Levels

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

Per level; Assessment applicable to coflex arm only. This is an assessment of the bone-implant interface.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=209 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Interface Remodeling - At Level(s) of Implant
NA
0 Levels
Interface Remodeling - At Level(s) of Implant
None
75 Levels
Interface Remodeling - At Level(s) of Implant
Mild
70 Levels
Interface Remodeling - At Level(s) of Implant
Moderate
16 Levels
Interface Remodeling - At Level(s) of Implant
Severe
20 Levels
Interface Remodeling - At Level(s) of Implant
Indeterminate
28 Levels

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

Per level; Assessment only applicable to coflex group. Device Condition in the investigational subjects was graded as: Intact, Deformed, Fractured, Migrated, or Dislodged.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=209 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Device Condition (Coflex Arm)
NA
0 Levels
Device Condition (Coflex Arm)
Intact
184 Levels
Device Condition (Coflex Arm)
Deformed
0 Levels
Device Condition (Coflex Arm)
Fractured
3 Levels
Device Condition (Coflex Arm)
Migrated
11 Levels
Device Condition (Coflex Arm)
Dislodged
0 Levels
Device Condition (Coflex Arm)
Indeterminate
11 Levels

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

Per level; This assessment is applicable to the fusion arm only. Device Condition in the control subjects will be graded as: Intact, Loose Screws, or Failed Hardware.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Device Condition (Fusion Control)
NA
0 Levels
Device Condition (Fusion Control)
Intact
90 Levels
Device Condition (Fusion Control)
Failed Graft
0 Levels
Device Condition (Fusion Control)
Loose Screws
10 Levels
Device Condition (Fusion Control)
Fractured Hardware
2 Levels
Device Condition (Fusion Control)
Indeterminate
9 Levels

OTHER_PRE_SPECIFIED outcome

Timeframe: 5 years

Population: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.

Per level; Assessment is applicable to coflex arm only. Device Mobility is an expected occurrence in some subjects and represents the amount of the of lift-off of the implant from the inferior spinous process.

Outcome measures

Outcome measures
Measure
Posterolateral Fusion w/Pedicle Screws
n=209 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Device Mobility
< 5 mm
181 Levels
Device Mobility
>= 5 mm
15 Levels
Device Mobility
Indeterminate
13 Levels
Device Mobility
NA
0 Levels

Adverse Events

Posterolateral Fusion w/Pedicle Screws

Serious events: 64 serious events
Other events: 101 other events
Deaths: 0 deaths

Coflex Interlaminar Technolgy

Serious events: 109 serious events
Other events: 199 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Posterolateral Fusion w/Pedicle Screws
n=107 participants at risk
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=215 participants at risk
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Musculoskeletal and connective tissue disorders
Component Loosening
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
1.4%
3/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Component Breakage
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Tear > 5mm
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Fracture
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
1.9%
4/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Hematoma Requiring Drainage
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Infection (deep)
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.93%
2/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Pain; new, increased frequency, or worsening
17.8%
19/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
13.5%
29/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Pseudarthrosis
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Wound problems
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
2.8%
6/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Metabolism and nutrition disorders
Other
10.3%
11/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
4.7%
10/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Cancer/Neoplasm
9.3%
10/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
2.3%
5/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Cardiac disorders
Cardiovascular
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
7.9%
17/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Ear and labyrinth disorders
Eye, Ear, Nose and Throat (EENT)
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Endocrine disorders
Endocrine/Metabolic
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
1.9%
4/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Gastrointestinal disorders
Gastrointestinal
5.6%
6/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
4.7%
10/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
General disorders
Genitourinary
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
2.3%
5/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Blood and lymphatic system disorders
Hematological
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Musculoskeletal
15.0%
16/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
14.9%
32/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Nervous system disorders
Neurological
3.7%
4/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
2.3%
5/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Psychiatric disorders
Psychiatric/Substance Abuse
2.8%
3/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Respiratory, thoracic and mediastinal disorders
Respiratory
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
2.3%
5/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Skin and subcutaneous tissue disorders
Skin and Subcutaneous
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure

Other adverse events

Other adverse events
Measure
Posterolateral Fusion w/Pedicle Screws
n=107 participants at risk
Control: Posterolateral fusion and implantation of pedicle screws after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Posterolateral Fusion and Implantation of Pedicle Screws
Coflex Interlaminar Technolgy
n=215 participants at risk
Investigative: Implantation of coflex Interlaminar Technology after decompression Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain Implantation of coflex Interlaminar Technology
Musculoskeletal and connective tissue disorders
Component Loosening
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Component Migration
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
1.4%
3/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Component Breakage
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
1.4%
3/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Incidental Durotomy (<= 5mm)
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Fracture
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
3.7%
8/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Nerve Injury
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Pain; new, increased frequency, or worsening
27.1%
29/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
28.4%
61/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Pseudarthrosis
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Wound problems
8.4%
9/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
11.2%
24/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Other
18.7%
20/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
21.4%
46/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Cancer/Neoplasm
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
2.8%
6/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Cardiac disorders
Cardiovascular
10.3%
11/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
7.0%
15/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Ear and labyrinth disorders
Eye, Ear, Nose, Throat (EENT)
3.7%
4/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
3.7%
8/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Endocrine disorders
Endocrine/Metabolic
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
4.7%
10/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Gastrointestinal disorders
Gastrointestinal
10.3%
11/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
5.1%
11/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
General disorders
Genitourinary
7.5%
8/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
5.1%
11/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Blood and lymphatic system disorders
Hematological
5.6%
6/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
3.3%
7/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Immune system disorders
Immune
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.93%
2/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Musculoskeletal and connective tissue disorders
Musculoskeletal
60.7%
65/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
55.3%
119/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Nervous system disorders
Neurological
21.5%
23/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
26.0%
56/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Psychiatric disorders
Psychiatric/Substance abuse
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Respiratory, thoracic and mediastinal disorders
Respiratory
6.5%
7/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
3.3%
7/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
Skin and subcutaneous tissue disorders
Skin and Subcutaneous Tissue
8.4%
9/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
7.4%
16/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure

Additional Information

Fran Magee, DVM

Paradigm Spine

Phone: 212-367-7274

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place